{"disease":{"id":"unresecable-stage-iiic-or-iv-melanoma","name":"unresecable stage iiic or iv melanoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03553329","title":"Study of the Variations of Albumin Level for Patients With Unresecable Stage IIIc or Stage IV Melanoma Treated by Anti BRAF and Anti MEK","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Poitiers University Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}